Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Any sight of our $$ yet??? Anything???.....So still Nothing???
What a shocker!!!
That one is the typical Pinky PD nonsense that ran on nothing news and hype, but was an $ATM$ all the same.
Not even in the same stratosphere as RVV IMO.
Was receiving High Volume alerts for the past 4-6 weeks but ignored them and lost out on an easy 12 bagger.
Oh well...........
Maybe Revive should have followed B##R and done a trial on 10 patients in India which was supposedly successful...now expanding to a whopping 65 patients.
Went from $0.045 on Tue to a high of $0.63 yesterday.
Can't wait for RVV to hopefully trade one day on a REAL exchange like the Nas or NYSE.....the Pinks are a complete joke. LOLOL
BTW....not a good idea to ignore alerts for abnormal Volume! SMH
That's the thing, they don't post DD but rather reinterpret basic info to fit the Escrow narrative....it's called confirmation bias.
The best part yet is when it's proven totally wrong the promoters go MIA until things "cool off" because the board has long moved onto the next fable.
It's keeps happening because very few call them out on it, and those that do are attacked by the "corns" as you already probably know.
Rinse, Repeat, Recycle...Rinse,..............................
Should have paid more attention to my Volume Alerts for this one.....CRAP!!!
WOW!!! Seems every time I think about cashing out something great like this happens. What's a few more months/year or two............
Impressive numbers by COOP, now if only the pps would actually reflect that instead of the values those inept ""analysts"" put out.
GLTA
Just read the "DON CHISCIOTTE" (huh? lolol) numps post...good grief!!!
It's as if this Escrow fable has altered reality for some so much so they are upset that COOP overperformed. Just demented!
In total agreement with you that RVV's core business will be Psychs, with Buc, if it works against Covid, being the "vehicle" used to further fund the development of our Psychedelic program.
I hate making this point but with the advent of Covid and the at times draconian measures instituted on the population, these actions are literally creating tens, if not hundreds of millions of potential new ""patients"" worldwide, in addition to making the condition of those already suffering much worse.
This does not only apply to adults, but even scarier is studies showing that children, especially in Urban Areas/Cities, are also being severely traumatized by this crisis.
This, IMO, does not bode well for the mental health of generations to come...hopeful this will not be the case.
FYI....not at all celebrating this tragedy in any way but simply pointing out a stark reality.
No worries. While everyone is focused on Covid RVV is slowly and without fanfare building a solid Psych portfolio. From delivery systems for treatments, an independent supply for Psilocybin, FDA studies/IND's etc etc. Very few companies in this space has so much going on. Just think how much all this could be ramped up to IF Buc Covid cash starts rolling in.
I know....one guy actually posted that the Philippines was conducting a trial on Ivermectin because the world does not trust it....HUH???
Had to point out that the drug has been safely used WORLDWIDE singe ~1975 to treat tens of millions of people.
Never seen anything like it...for a Biotech stock.
I hope the people doing all the leg work to promote Leron by writing letters, emails, posts and other marketing strategies will be paid for their efforts.
If successful Leron will likely be the FIRST drug to ever receive an EUA due to an ""$ organic $"" grassroots effort from a Stock Msg Board. LOL
Looks like everyone on the sidelines is waiting for the Covid Trial results. All these other developments, which if Pr'd by other companies would be "BIG NEWS", is treated like a "nothing burger" for Revive.
What makes Buc even better is that it's a Dual-Thiol Donor.
Someone had posted a list of Thiols last year and Buc was one of a few, ?3-5 drugs?, that have this ability.
Agreed, that's why I'm willing to be patient with the Trials so that they get it right the first time.
You never know, Buc could soon become a household name outside of East Asia. LOL
I ?believe? it will vary based on the quality and efficacy shown by the data, AND political influence.
Saw one granted after about ~2 weeks but that was for Remdesivir.
Others have taken 4+ weeks before being granted so I guess expect anywhere from 4-8 weeks.
Hopefully our data will allow for an EUA in the shortest possible timeframe.
Link to EUA application for Remdesivir (from CYDY Board)
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=162723429
Added it to my watchlist a couple months ago when researching cancer stocks but recently was paying little attention.
Like the fact that the treatment is simple, relatively non invasive and apparently not taxing on the body like Chemo.
If the testing proves to be successful sub 10 is an insane bargain.
Watching closely....thanks for the heads up!
So basically you are an expert on research into the potential long term effects of mRNA vaccines even though literally NO ONE knows what their effects, adverse or otherwise, will be?
That's really amazing!
Btw, what World renowned research institution do you lead/work for!?!
You do realise that this is the Revive board so you could have at least mentioned RVV somewhere in your post.
To answer your question...No, but I will be flipping the Crap out of it as I did Friday after the news broke to once again capitalize on the HYPE.
The Philippine medical establishment does not trust Ivermectin?
A drug discovered and widely used all over the world since 1975, unto this day???
What utter rubbish.
Wait a minute....didn't a certain Bond Owner here claim that JPM will assume and pay the WMB Snr and Sub Bonds???
From the FDIC response to PP....post# 655099
Please note, however, that when the bank failed, NONE of the outstanding senior bonds and subordinated bonds previously issued by Washington Mutual Bank were acquired by JPMorgan Chase Bank, N.A. as part of the P&A Agreement with the FDIC-Receiver. Instead, the FDIC-Receiver retained those liabilities, and they remain on the receivership’s balance sheet to this day. This means that JPMorgan Chase Bank has absolutely no responsibility to pay those bonds. Only the FDIC-R has an obligation to pay those bonds … but only if there are sufficient funds in the receivership to make any payments on them.
Nice.........
Reading between the lines....expansion of the Trial DOES NOT, IMO, equate to mediocre/poor study results .
The DSMB must like what they are seeing so far.
Demand for vaccines is falling in the US so this could trigger the export of excess supply to nations that need/want it.
Quote: "which is based on nothing but hype IMO, but has greatly diminished lately."
So the meteoric rise from <$1 to $5-$6, now back to $2, was based on what tangible products or revenue Mind has so far delivered?
Jack Torrance Member Level
Friday, 04/23/21 08:06:25 AM
Re: kayoboi post# 5318
Post #5321 of 5321
Spiking to $10 isn't out of the realm of possibility in the next week or two, but I don't think it settles at that price after the hype wears off. I think in 2 weeks this is trading at around $6 USD.
You can't write this stuff....what a total jackass!
Which company has a FDA Trial currently in Phase 2-3 testing?
Good thing I could care less about what you think.
Are you this desperate for attention or just mental!!!
That was before the start of the Trial when no one knew for sure what was facing the world....during the course of it the DSMB reviews the data and in consultation with the sponsor a recommendation could have been made to increase the doses if it was viable. Was that done and the FDA denied it?...I call BS!
I reiterate again....the FDA does not run Trials nor is it responsible for unilaterally making decisions about how a company's trial is conducted. How stupid is that theory...........
The FDA didnt run CYDN's Trial so they were not responsible for adding extra doses as CTM claimed.
What part of this do you not get!
And you had to use a post to vent because my statement triggered you?
Stop being a pu $ $ y and just do it already.
You temperamental assclowns are really pathetic!
https://recentlyheard.com/2021/04/22/report-pfizer-vaccine-causes-neurodegenerative-diseases/
Not sure how legit this source is but they are quoting a study done by the National Library of Medicine. Take it for what it is.........
Exactly....there are concerns being expressed by some that Covid cases are dwindling so we may have missed the boat. Nothing could be further from the truth IMO since, I believe, our trial may be focused on developing a long term Therapeutic for Covid, Variants, and the next virus that will inevitably surface in time. I also suspect that the push to get as many as possible vaccinated has not been fully exhausted, thus Therapeutics will remain the secondary focus. I am 100% for RVV/DSMB/FDA taking the necessary time to conduct a thorough Trial that will hopefully result in Buc or a Buc based therapy becoming, THE GO-TO FLU/VIRUS treatment for years/decades to come.
AIMHOOC
Quote: "Wrong Dose - Works great when given (82% better!). Stop giving, stops working. Hello, FDA? Where are doses 3 and 4?"
The line in red is utter nonsense from CTMedic. The FDA HAS NOTHING TO DO WITH CONDUCTING TRIALS!!! You obviously have no idea what your're talking about and so does CTM.
It is the DSMB that sees and evaluates the data and then makes decisions based on this data on how the trials are continued and/or modified....AGAIN NOT THE FDA.
The FDA only evaluates the data presented to them and comes to a decision on whether to approve or not.
EDIT: Showed you the facts, you respond with gibberish...impressive!!!
Since you seem to think you know so much maybe you should make yourself available to Cytodyn to conduct their Trials.
Btw...you do know that the FDA DOES NOT conduct or have any input into Drug Trials for any company.
Not sure why you're querying them about missed doses....it was either Cyto staff or those they hired that botched the job.
But you already knew that I'm sure...........LOL
Quote: "No one is crying as no one cares if the stock goes up or down"
We all care whether the stock goes up or down......ie, after the Trial results hopefully reveal that Buc indeed works.
For the time being, the lack of pps action, without any meaningful catalyst to drive it, is irrelevant IMO.
I regularly get the impression that some people would prefer that MF ran RVV like the typical POS Pinky.
Cytodyn should use that in a Covid commercial.
Leronlimab....it will add 2 weeks to your life....well probably!
Good grief!!!
Wait!..what!!! Is that the actual efficacy numbers?
So if there were 100 patients Leeroy saved about 4 out of the 16 patients data that they selected to present?
This is what all the excitement is about.......WOW!!!
Said the poof who keeps responding to my posts to other people....shit for brains.......
It's YOU who keeps responding to my posts on the COOP board, not the other way around jackass.
What a fukin clown. LOLOL
In case you haven't noticed I have long moved on to other stocks from which I've benefitted greatly and will continue to in the coming months.
I continue to visit the COOP board because I still own all my Newco stock that I received in 2012.
I respond to the Escrow nonsense because I can, same as YOU DO, so I find your question to be foolish.
Was that clear enough you deluded assclown!?!!
Correct Mindmed is far away from Revive....far behind in everything except it's pps....which is based on nothing but hype IMO, but has greatly diminished lately.
Are they even conducting any FDA Trials on their Psych portfolio or is it all Euro based?
All the while Revive has multiple ongoing Trials/IND's for Covid, CBD's, Psych Delivery Methods and Psych's themselves.
Revive is slowly, with little fanfare, building it's Psychedelic portfolio by investing/engaging in collaborative research into Delivery Systems for Treatments and securing it's own Production and Supply of Psilocybin.
?When? this Sector becomes mainstreamed for treating persons with psychological issues the company will be well positioned to take a leading role because of these actions, especially re the delivery of Psych doses....have seen only one other company doing official research in this area.
As for our current position, the only ones complaining are those who have become impatient, which I fully understand, and those who are desperate for Revive's stock to go parabolic so they can flip.
Which group do you fall under!?!
Companies pulling a fast one will PR that they are conducting Trials but will invest as little as possible, hence the small cohort of patients.
The data collected from that Trial is more than likely worthless to the FDA.